| pubmed-article:19097891 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19097891 | lifeskim:mentions | umls-concept:C1566558 | lld:lifeskim |
| pubmed-article:19097891 | lifeskim:mentions | umls-concept:C0020202 | lld:lifeskim |
| pubmed-article:19097891 | lifeskim:mentions | umls-concept:C0206131 | lld:lifeskim |
| pubmed-article:19097891 | lifeskim:mentions | umls-concept:C1999216 | lld:lifeskim |
| pubmed-article:19097891 | lifeskim:mentions | umls-concept:C1522538 | lld:lifeskim |
| pubmed-article:19097891 | lifeskim:mentions | umls-concept:C0620729 | lld:lifeskim |
| pubmed-article:19097891 | lifeskim:mentions | umls-concept:C0245048 | lld:lifeskim |
| pubmed-article:19097891 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:19097891 | pubmed:dateCreated | 2009-1-27 | lld:pubmed |
| pubmed-article:19097891 | pubmed:abstractText | Based on the structural similarity between the naturally occurring cyclic heptapeptides rhizonin A and ternatin, two novel analogues were designed. The synthetic analogues were assessed with regard to their fat-accumulation inhibitory effect against 3T3-L1 adipocytes, and this led to the discovery of a potent and selective fat-accumulation inhibitor compared to the parent compound rhizonin A. | lld:pubmed |
| pubmed-article:19097891 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19097891 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19097891 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19097891 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19097891 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19097891 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19097891 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19097891 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19097891 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19097891 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:19097891 | pubmed:issn | 1464-3405 | lld:pubmed |
| pubmed-article:19097891 | pubmed:author | pubmed-author:UemuraDaisuke... | lld:pubmed |
| pubmed-article:19097891 | pubmed:author | pubmed-author:YamadaKaoruK | lld:pubmed |
| pubmed-article:19097891 | pubmed:author | pubmed-author:ShimokawaKeni... | lld:pubmed |
| pubmed-article:19097891 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19097891 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:19097891 | pubmed:volume | 19 | lld:pubmed |
| pubmed-article:19097891 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19097891 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19097891 | pubmed:pagination | 867-9 | lld:pubmed |
| pubmed-article:19097891 | pubmed:meshHeading | pubmed-meshheading:19097891... | lld:pubmed |
| pubmed-article:19097891 | pubmed:meshHeading | pubmed-meshheading:19097891... | lld:pubmed |
| pubmed-article:19097891 | pubmed:meshHeading | pubmed-meshheading:19097891... | lld:pubmed |
| pubmed-article:19097891 | pubmed:meshHeading | pubmed-meshheading:19097891... | lld:pubmed |
| pubmed-article:19097891 | pubmed:meshHeading | pubmed-meshheading:19097891... | lld:pubmed |
| pubmed-article:19097891 | pubmed:meshHeading | pubmed-meshheading:19097891... | lld:pubmed |
| pubmed-article:19097891 | pubmed:meshHeading | pubmed-meshheading:19097891... | lld:pubmed |
| pubmed-article:19097891 | pubmed:meshHeading | pubmed-meshheading:19097891... | lld:pubmed |
| pubmed-article:19097891 | pubmed:meshHeading | pubmed-meshheading:19097891... | lld:pubmed |
| pubmed-article:19097891 | pubmed:meshHeading | pubmed-meshheading:19097891... | lld:pubmed |
| pubmed-article:19097891 | pubmed:meshHeading | pubmed-meshheading:19097891... | lld:pubmed |
| pubmed-article:19097891 | pubmed:meshHeading | pubmed-meshheading:19097891... | lld:pubmed |
| pubmed-article:19097891 | pubmed:meshHeading | pubmed-meshheading:19097891... | lld:pubmed |
| pubmed-article:19097891 | pubmed:meshHeading | pubmed-meshheading:19097891... | lld:pubmed |
| pubmed-article:19097891 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:19097891 | pubmed:articleTitle | Structure-based hybridization of the bioactive natural products rhizonin A and ternatin leading to a selective fat-accumulation inhibitor against 3T3-L1 adipocytes. | lld:pubmed |
| pubmed-article:19097891 | pubmed:affiliation | Department of Chemistry, Graduate School of Science, Nagoya University, Furo-cho, Chikusa, Nagoya 464-8602, Japan. | lld:pubmed |
| pubmed-article:19097891 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19097891 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | pubmed-article:19097891 | lld:chembl |
